FindTrial
Sign In

Exploratory research of biomarkers for investigational drugs using tear fluid samples

Exploratory research of biomarkers for investigational drugs using tear fluid samples - Exploratory research of biomarkers for investigational drugs using tear fluid samples

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049186
Enrollment
29
Registered
2022-10-13
Start date
2022-09-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction

Interventions

None listed

Sponsors

Santen Pharmaceutical Co. Ltd.
Lead Sponsor
Singapore Eye Research Institute
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who received an investigational drug including placebo at the study sites and consented to the collection and use of tear fluid samples

Exclusion criteria

Exclusion criteria: Subjects who were unable to calculate the ratio of pre- and post-treatment expression level due to the absence of either sample or subjects who withdrew their consent to opt-out.

Design outcomes

Primary

MeasureTime frame
Expression profile (e.g., protein)—

Countries

Asia(except Japan)

Contacts

Public ContactHiroyuki Shimizu

Santen Pharmaceutical Co. Ltd. Ophthalmology Innovation center

clinical@santen.com06-4802-9339

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026